Avastin Injection Consent
Avastin Injection Consent
Avastin Injection Consent
Once a device or medication is approved by the FDA, physicians may use it “off-label” for other purposes
if they are well-informed about the product, base its use on firm scientific method and sound medical
evidence, and maintain records of its use and effects. Ophthalmologists are using AvastinTM “off-label” to
treat AMD and similar conditions since research indicates that VEGF is one of the causes for the growth
of the abnormal blood vessels that cause these conditions. Some patients treated with AvastinTM had less
fluid and more normal-appearing maculas, and their vision improved. AvastinTM is also used, therefore, to
treat macular edema, or swelling of the macula. Recently, a medication similar in function and designed
for intravitreal administration was approved by the FDA for the treatment of AMD.
ALTERNATIVES
You do not have to receive treatment for your condition, although without treatment, these diseases can
lead to further vision loss and blindness, sometimes very quickly. Other forms of treatment are available.
At present, there are three FDA-approved treatments for neovascular age-related macular degeneration.
The first two are photodynamic therapy with a drug called VisudyneTM and injection into the eye of a dug
called MacugenTM. Although both of these treatments have been proved to slow down the rate of visual
loss, most people do not get back better vision. The third medication, LucentisTM is similar to AvastinTM.
Your doctor will discuss with you the benefits and risks associated with these other choices of treatment.
In addition to the FDA-approved medications, some ophthalmologists use intravitreal Triamcinolone
Acetonide –a long-acting cortisone-like drug- “off-label” to treat eye conditions like yours.
Although the likelihood of serious complications affecting other organs of my body is low, I will
immediately contact my primary care physician or go to the emergency room if I experience abdominal
pain associated with constipation and vomiting, abnormal bleeding, chest pain, severe headache, slurred
speech, or weakness on one side of the body. As soon as possible, I will also notify my ophthalmologist
of these problems.
I will inform my ophthalmologist if I need to have any surgery, and I will inform any other surgeon,
including dentists, that I am on a medication that needs to be stopped before I can have surgery.
PATIENT CONSENT
The above explanation has been read by/to me. The nature of my eye condition has been explained to me
and the proposed treatment has been described. The risks, benefits, alternatives, and limitations of the
treatment have been discussed with me. All my questions have been answered.
I understand that AvastinTM was approved by the FDA for the treatment of metastatic colorectal cancer,
and has not been approved for the treatment of eye conditions. Nevertheless, I wish to be treated with
AvastinTM, and I am willing to accept the potential risks that my physician has discussed with me.
____________________________________ ________________________
Patient’s Signature Date
____________________________________ ________________________
Witness’s Signature Date
____________________________________ ________________________
Physician’s Signature Date